Autopsy report · NCT03153956

Efficacy of AposTherapy® in Knee OA

“Halt in funding”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 years 1 month after it had already started.
• Ran for about 3 years 7 months before it stopped.
• 77 participants enrolled.
• Results were posted on the registry 1 year 4 months after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

NYU Langone Health

Sponsor type

University, hospital or other

Conditions

Osteoarthritis, Knee

Interventions

Calibrated AposTherapy®; Non-Calibrated Sham Apos Therapy Device

Participants

77

Sites

1

Countries

United States

Trials that died the same way

• Clinical, Pharmacological and Molecular Effects of IV and Oral Acetaminophen in Adults With aSAH
  “Funding was stopped” (77% match in meaning)
• Effectiveness of the Rapid Intravascular Start (RIVS) System Versus Conventional Catheter
  “Funding Stopped” (77% match in meaning)
• HCV Test and Treat Utilizing Simplified HCV Patient Education
  “The funding was halted.” (76% match in meaning)
• Success of Long-acting Anti-inflammatories After Anterior Cruciate Ligament and Meniscal Injury
  “Funding Termination” (76% match in meaning)
• A Novel Mobile Health Intervention for Improving Tobacco Cessation Among Young Adults
  “Discontinuation of funding” (73% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.